enVVeno Medical Corp Cash and Restricted Cash
enVVeno Medical Corp (NVNO) had Cash and Restricted Cash of $9.33 million as of 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-03-31
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.33M.
- 2020-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.63M.
- 2020-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.37M.
- 2020-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.53M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2020-12-31 | $9.33M 10-K · filed 2021-03-31 |
| 2020-09-30 | $5.63M 10-Q · filed 2020-11-17 |
| 2020-06-30 | $2.37M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.53M 10-Q · filed 2020-06-08 |
| 2019-12-31 | $2.12M 10-K · filed 2021-03-31 |
| 2019-09-30 | $3.75M 10-Q · filed 2020-11-17 |
| 2019-06-30 | $5.28M 10-Q · filed 2020-08-14 |
| 2019-03-31 | $3.56M 10-Q · filed 2020-06-08 |
| 2018-12-31 | $2.74M 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |